Before merging, the process of discovering drugs at GSK, as well as SKB, had similarities based on the industry standards. It ran in an order, respectively to Pre-discovery Research is the initial stage to identify the target of the drug through screening for bind ability with the target. Which was followed by Lead optimization, the lead was tried against various animal disease models considering numerous features such as the extent of the activity. The Preclinical evaluation followed for only prospective drugs. It entailed consideration of toxicity and its effectiveness against more detail-oriented model diseases. After that, it ran in Continue reading...
